Discover

OMIC
Singular Genomics Systems, Inc.
20.01
undefined x undefined
undefined x undefined
bid
ask
+
20.01
0.00%
07:00 PM
Ytd
1y
day range
52 week range
OpenPrev CloseLowHighMkt CapN/A
Vol0.00Avg Vol0.00EPSN/AP/EN/AForward P/E-0.61
Beta1.51Short Ratio2.30Inst. Own60.22%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est12.45
Income Statement
Total Revenue406.00K
Revenues (USD)406.00K
Cost of Revenue707.00K
Gross Profit-301.00K
Operating Expenses17.77M
Research and Development Expense9.57M
Selling, General and Administrative Expense8.20M
Operating Income-18.07M
Interest Expense286.00K
Net Income-16.80M
Net Income Common Stock-16.80M
Net Income Common Stock (USD)-16.80M
Consolidated Income-16.80M
Earnings per Basic Share-6.72
Earnings per Basic Share (USD)-6.72
Earnings per Diluted Share-6.72
Earning Before Interest & Taxes (EBIT)-16.51M
Earning Before Interest & Taxes (USD)-16.51M
Weighted Average Shares2.50M
Weighted Average Shares Diluted2.50M
Balance Sheet
Cash and Equivalents53.22M
Cash and Equivalents (USD)53.22M
Investments61.21M
Investments Current61.21M
Trade and Non-Trade Receivables183.00K
Current Assets129.81M
Property, Plant & Equipment Net55.07M
Total Assets186.55M
Debt Current5.47M
Total Debt50.49M
Current Liabilities17.61M
Debt Non-Current45.02M
Total Liabilities63.30M
Accumulated Retained Earnings (Deficit)-400.67M
Accumulated Other Comprehensive Income83.00K
Shareholders Equity123.25M
Shareholders Equity (USD)123.25M
Assets Non-Current56.74M
Total Debt (USD)50.49M
Inventory12.41M
Liabilities Non-Current45.69M
Trade and Non-Trade Payables1.88M
Cash Flow
Depreciation, Amortization & Accretion1.69M
Net Cash Flow / Change in Cash & Cash Equivalents22.51M
Capital Expenditure-7.00K
Net Cash Flow from Investing42.29M
Net Cash Flow - Investment Acquisitions and Disposals42.30M
Net Cash Flow from Operations-19.79M
Share Based Compensation2.17M